Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.
Journal: Seminars in arthritis and rheumatism
Published: November 19, 2025
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023.
Journal: Seminars in arthritis and rheumatism
Published: October 23, 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Journal: Seminars in arthritis and rheumatism
Published: August 25, 2023
Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.
Journal: Molecules (Basel, Switzerland)
Published: December 30, 2020
Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the Knee.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 03, 2018
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.
Journal: The Journal of rheumatology
Published: May 31, 2016
JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers.
Journal: Clinical and translational medicine
Published: April 01, 2016
Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014.
Journal: The Journal of rheumatology
Published: September 17, 2015
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
Journal: Annals of the rheumatic diseases
Published: May 21, 2015
Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop.
Journal: The Journal of rheumatology
Published: May 17, 2015
Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Journal: The New England journal of medicine
Published: April 16, 2015
Last Updated: 09/26/2026